SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: AntagoNATs that upregulate SCN1A expression (Hsiao et al., 2016) are currently in the IND-enabling stage at CuRNA/OPKO (Dravet Syndrome; CuRNA/OPKO, 2020).